GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » E10

Aarti Drugs (BOM:524348) E10 : ₹18.49 (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Aarti Drugs's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹4.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹18.49 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Aarti Drugs's average E10 Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-26), Aarti Drugs's current stock price is ₹344.95. Aarti Drugs's E10 for the quarter that ended in Dec. 2024 was ₹18.49. Aarti Drugs's Shiller PE Ratio of today is 18.66.

During the past 13 years, the highest Shiller PE Ratio of Aarti Drugs was 38.62. The lowest was 18.38. And the median was 28.80.


Aarti Drugs E10 Historical Data

The historical data trend for Aarti Drugs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs E10 Chart

Aarti Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 14.42 16.25 17.72

Aarti Drugs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.58 17.72 18.11 18.42 18.49

Competitive Comparison of Aarti Drugs's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Drugs's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aarti Drugs's Shiller PE Ratio falls into.



Aarti Drugs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aarti Drugs's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=4.06/158.3229*158.3229
=4.060

Current CPI (Dec. 2024) = 158.3229.

Aarti Drugs Quarterly Data

per share eps CPI Adj_EPS
201503 1.911 97.163 3.114
201506 1.795 99.841 2.846
201509 1.623 101.753 2.525
201512 1.758 102.901 2.705
201603 1.920 102.518 2.965
201606 2.053 105.961 3.068
201609 2.278 105.961 3.404
201612 1.890 105.196 2.845
201703 2.302 105.196 3.465
201706 1.193 107.109 1.763
201709 2.473 109.021 3.591
201712 2.445 109.404 3.538
201803 2.543 109.786 3.667
201806 2.455 111.317 3.492
201809 1.913 115.142 2.630
201812 2.215 115.142 3.046
201903 3.015 118.202 4.038
201906 2.390 120.880 3.130
201909 3.468 123.175 4.458
201912 2.980 126.235 3.737
202003 6.352 124.705 8.064
202006 9.170 127.000 11.432
202009 8.080 130.118 9.831
202012 7.300 130.889 8.830
202103 5.550 131.771 6.668
202106 5.250 134.084 6.199
202109 4.600 135.847 5.361
202112 6.290 138.161 7.208
202203 5.976 138.822 6.815
202206 3.757 142.347 4.179
202209 4.180 144.661 4.575
202212 3.961 145.763 4.302
202303 6.057 146.865 6.530
202306 5.167 150.280 5.444
202309 4.290 151.492 4.483
202312 3.990 152.924 4.131
202403 5.090 153.035 5.266
202406 3.615 155.789 3.674
202409 3.830 157.882 3.841
202412 4.060 158.323 4.060

Add all the adjusted EPS together and divide 10 will get our e10.


Aarti Drugs  (BOM:524348) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Aarti Drugs's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=344.95/18.49
=18.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Aarti Drugs was 38.62. The lowest was 18.38. And the median was 28.80.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Aarti Drugs E10 Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Drugs Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.

Aarti Drugs Headlines

No Headlines